Brief: PCI Biotech Holding Q4 operating loss widens to NOK 10.3 million
Feb 24 (Reuters) - PCI Biotech Holding ASA PCIB.OL :
* Q4 operating loss 10.3 million Norwegian crowns ($1.35
million) versus loss 9.3 million crowns year ago
* Q4 pre-tax loss 10.2 million crowns versus loss 8.8
million crowns year ago
Source text for Eikon: urn:newsml:reuters.com:*:nHUG4Ws0s9
Further company coverage: PCIB.OL
($1 = 7.6149 Norwegian crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process